02252.HK
Shanghai MicroPort MedBot (Group) Co., Ltd.
HKSE · Healthcare · Medical - Devices · CN
HKD 21.18
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 808.3M | 551.1M | 257.2M | 104.6M | 21.6M |
| Cost of Revenue | 455.5M | 284.4M | 171.0M | 89.9M | 15.0M |
| Gross Profit | 352.8M | 266.6M | 86.2M | 14.7M | 6.6M |
| Operating Expenses | |||||
| R&D Expense | 524.7M | 216.0M | 308.7M | 569.2M | 755.8M |
| SG&A Expense | 512.5M | 249.2M | 263.2M | 364.8M | 354.5M |
| General & Admin Expense | 100.9M | 45.6M | 55.3M | 126.4M | 170.5M |
| Selling & Marketing Expense | 411.5M | 203.6M | 207.9M | 238.4M | 184.0M |
| Other Expenses | 39.7M | 36.7M | 3.0M | 55.9M | (5.0M) |
| Total Operating Expenses | 1.1B | 501.9M | 575.0M | 989.8M | 1.1B |
| Cost and Expenses | 1.5B | 786.3M | 746.0M | 1.1B | 1.1B |
| Operating Income (EBIT) | (724.0M) | (235.3M) | (488.8M) | (975.1M) | (1.1B) |
| Non-Operating | |||||
| Interest Income | 9.5M | 6.8M | 2.2M | 8.7M | 26.7M |
| Interest Expense | 25.8M | 19.7M | 21.5M | 18.4M | 11.1M |
| Net Interest Income | (23.0M) | (12.8M) | (19.3M) | (9.7M) | 15.5M |
| Other Non-Op Income/Expense | (177.2M) | (18.9M) | (158.3M) | (48.4M) | (51.0M) |
| Non-Operating Income (excl Interest) | (78.6M) | (64.3M) | (14.4M) | 30.0M | 1.7M |
| EBT (Pre-Tax Income) | (901.2M) | (254.1M) | (647.1M) | (1.0B) | (1.1B) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (892.1M) | (249.7M) | (642.4M) | (1.0B) | (1.1B) |
| Earnings from Cont. Ops | (901.2M) | (254.1M) | (647.1M) | (1.0B) | (1.1B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (892.1M) | (249.7M) | (642.4M) | (1.0B) | (1.1B) |
| Per Share | |||||
| Basic EPS | (HK$0.90) | (HK$0.24) | (HK$0.66) | (HK$1.06) | (HK$1.19) |
| Diluted EPS | (HK$0.90) | (HK$0.24) | (HK$0.66) | (HK$1.06) | (HK$1.19) |
| Revenue Per Share | HK$0.78 | HK$0.54 | HK$0.27 | HK$0.11 | HK$0.02 |
| Shares | |||||
| Basic Shares Outstanding | 1.0B | 1.0B | 966.9M | 958.6M | 958.6M |
| Diluted Shares Outstanding | 1.0B | 1.0B | 966.9M | 958.6M | 958.6M |
| Profitability Metrics | |||||
| EBITDA | (493.9M) | (96.8M) | (413.3M) | (893.4M) | (1.1B) |
| D&A | 151.4M | 74.2M | 61.0M | 111.8M | 42.5M |
| EBIT | (645.4M) | (171.0M) | (474.4M) | (1.0B) | (1.1B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025